Brain-Derived Neurotrophic Factor

Definition

Brain-derived neurotrophic factor, or BDNF, is a signaling protein associated with neuronal survival, learning, memory, synaptic change, and the capacity of active circuits to reorganize.

Current Synthesis

In Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity, BDNF is the bridge between ketamine-induced circuit activity and possible longer-term change. NMDA blockade on inhibitory neurons is proposed to permit excitatory burst firing, which may recruit BDNF and make active circuits more plastic.

The source supports that bridge with three kinds of evidence: learned-helplessness effects are reduced in mice lacking BDNF, some people with a BDNF variant reportedly respond less strongly to ketamine, and ketamine is proposed to interact with the BDNF receptor TrkB. Together these observations motivate a mechanism, but they do not establish that BDNF alone explains clinical response or that increasing BDNF is a treatment protocol.

Key Claims

• BDNF participates in learning-, memory-, growth-, and circuit-change processes.
• Ketamine-related burst firing may recruit BDNF signaling during a temporary plasticity window.
• Animal loss-of-function evidence supports BDNF involvement without directly proving the human antidepressant pathway.
• Human genetic response differences suggest moderation rather than a simple responsive-versus-nonresponsive biomarker.
• Proposed TrkB interaction expands the model beyond BDNF release but remains source-scoped.

Evidence

• Animal necessity signal - Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity says mice lacking BDNF do not show the usual ketamine-related learned-helplessness effect.
• Human-response moderation - Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity says people with a BDNF variant show reduced ketamine response.
• Receptor hypothesis - Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity presents ketamine binding to TrkB as a proposed growth-factor-like mechanism.
• Circuit link - Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity connects disinhibition and excitatory burst firing to BDNF recruitment and plasticity.

Counterevidence & Qualifications

The source note does not provide study methods, effect sizes, variant definitions, replication status, dose dependence, or evidence that BDNF measurement can select treatment. Learned helplessness is a limited animal model, reduced response is not no response, and BDNF signaling is not synonymous with beneficial change. No supplement, exercise, drug, or behavior protocol is inferred from the mechanism.

What Changed

• Added BDNF as a bounded bridge between ketamine-related burst firing and longer-term plasticity.
• Separated animal, human-variant, and receptor-binding evidence instead of treating them as one proof.

Related Concepts

• Neuroplasticity / 神经可塑性 - broader circuit-change framework in which BDNF participates.
• Ketamine Antidepressant Mechanisms - treatment-mechanism context supplying the current evidence.
• Ketamine Treatment and Safety - clinical boundary preventing a molecular hypothesis from becoming self-treatment advice.
• Circuit-Based Psychiatry - network-level frame in which trophic signaling may support recalibration.